Crystal form of a dithiolene metal complex

Phosphoramidate compound and preparation method and crystal thereof

Process for the preparation of 5-(4-cyanophenoxy)-1,3-dihydro-1-hydroxy-[2,1]-benzoxaborole and polymorphs thereof

Solid state forms of ixazomib citrate

Ribociclib salts and solid state forms thereof

Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereof

Crystalline forms of a MAGL inhibitor

Crystalline form of orexin receptor antagonist, processes for preparation thereof and use thereof

Crystalline forms of 4-(2-((1R,2R)-2-hydroxycyclohexylamino)benzothiazol-6-yloxy)-N-methylpicolinamide

Method for producing 2-acetyl-4H,9H-naphtho[2,3-b]furan-4,9-dione

Crystalline solid forms of N-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-N′-(4-fluorophenyl) cyclopropane-1,1-dicarboxamide, processes for making, and methods of use

Solid forms of berberine ursodeoxycholate and compositions and methods thereof

Crystalline forms of nicotinoyl ribosides and derivatives thereof, and methods of preparation thereof

Polymorphs of dolutegravir and salts thereof

Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof

Crystalline forms of diazabicyclooctane derivative and production process thereof

Diacylglycerol acyl transferase 2 inhibitors

Cocrystal of Telmisartan and Hydrochlorothiazide

CGRP receptor antagonists

Crystalline and salt forms of PPAR agonist compounds

Gadobutrol intermediate and gadobutrol production method using same

Crystalline form of 1-(5-(2,4-difluorophenyl)-1-((3-fluorophenyl)sulfonyl)-4-methoxy-1H-pyrrol-3-yl)-N-methylmethanamine salt

Recording material, and recording sheet

HIGHLY ACTIVE DRUG COMBINATION FOR TREATMENT OF HEPATITIS C VIRUS

Crystalline form C of shuangzuocaotong, preparation method therefor and use thereof

Crystals of cyclic amine derivative and pharmaceutical use thereof

2-[4-(meihylaminomethyl)phenyl]-5-fluoro- benzofuran-7-carboxamide hydrochloride polymorph, preparation method therefor and application thereof

Pyrimidine derivative

Process for the preparation of HIV integrase inhibitors

Substituted Phenethylamines with Serotoninergic and/or Norepinephrinergic Activity

Co-crystals of tramadol and coxibs

Preparation of and formulation comprising a MEK inhibitor

Process for preparing 7H-pyrrolo[2,3-d]pyrimidine derivatives and co-crystals thereof

Crystalline of camphorsulfonic acid salt of rucaparib and method of preparing of tricyclic compounds, rucaparib and crystalline of camphorsulfonic acid salt of rucaparib

Small molecule inhibitors of the JAK family of kinases

Inhibitors of ROR gamma

Crystalline form of N-[1-(5-cyano-pyridin-2- ylmethyl)-1H-pyrazol-3-yl]-2-[4-(1-trifluoromethyl-cyclopropyl)-phenyl]-acetamide

Process for the manufacture of vortioxetine HBr alpha-form

Crystal forms and production methods thereof

Amorphous form of vilanterol trifenatate and processes for the preparation thereof

Crystalline forms of 5-bromo-2,6-di(1H-pyrazol-1-yl)pyrimidin-4-amine and new salts

Enhanced perovskite materials for photovoltaic devices

Crystal characteristics, preparation processes and anticancer applications of 17beta-neriifolin crystal forms

Crystal forms of β-nicotinamide mononucleotide

Enhanced perovskite materials for photovoltaic devices

Polymorphs of dolutegravir and salts thereof

Crystalline forms of salts of fused penta-cyclic dihydrodiazepinocarbazolones, and uses thereof

NOVEL SALTS AND CRYSTALS

Cooling composition

Crystal form of deuterated AZD9291, preparation method therefor, and use thereof

Crystalline forms of ozanimod and ozanimod hydrochloride, and processes for preparation thereof

Crystalline (2S,4R)-5-(5′-chloro-2′-fluoro-[1,1′-biphenyl]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2-methylpentanoic acid and uses thereof

Type-G crystal form of fenolamine, preparation method, composition and use thereof

Crystalline forms of hydroxynorketamine

Processes of making L-ornithine phenylacetate

Enzymatic process for obtaining 17 α-monoesters of cortexolone and/or its 9,11-dehydroderivatives

Solid forms for a thienopyrimidinedione ACC inhibitor and methods for production thereof

CRYSTALLINE FORMS OF A BRUTONS TYROSINE KINASE INHIBITOR

Solid dispersions of amorphous Lumateperone p-Tosylate

Crystalline spirocyclic compound, a dosage form containing, a method for using in treatment of disease, and a method for recrystallizing

Processes for preparing an FGFR inhibitor

Inhibitors of RORγ

Nicotine salts, co-crystals, and salt co-crystal complexes

Synthesis of triethylenetetramines

CRYSTALLINE FORMS OF PITAVASTATIN CALCIUM

Crystalline forms of vilanterol trifenatate and processes for their preparation

Industrial preparation method for high-purity dicycloplatin needle-like crystal

5,8-DIMETHYL-2-[2-(1-METHYL-4-PHENYL-1H-IMIDAZOL-2-YL)-ETHYL]-[1,2,4]TRIAZOLO[1,5-A]PYRAZINE HEMIADIPATE

Solid forms of tetrahydropyranyl amino-pyrrolopyrimidinone compounds

Pyrimidine compound as JAK kinase inhibitor

Process for preparing alectinib or a pharmaceutically acceptable salt thereof

Salt forms of 4-cyano-N-(4,4-dimethylcyclohex-1-en-1-yl)-6-(2,2,6,6-Tetr amethyltetrahydro-2H-pyran-4-yl)pyridin-3-yl)-1H-imidazole-2-carboximide

Crystalline forms of 6-((6,7-dimethoxyquinazolin-4-yl)oxy)-N,2-dimethylbenzofuran-3-carboxamide

Enantiomerically purified GPER agonist for use in treating disease states and conditions

Salt and polymorph of benzopyrimidinone compound and pharmaceutical composition and use thereof

Crystalline 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione hemihydrate, compositions and methods of use thereof

Crystalline salts of a plasma kallikrein inhibitor

Crystalline form of N-butyldeoxygalactonojirimycin

Sodium methyl glycine-N,N-diacetic acid compound, process to prepare it and use thereof

Crystal form of sodium-glucose cotransporter 2 inhibitor

Crystal structure-modulated zeolitic imidazolate framework nanoparticles and method of producing the same

Crystal of cephalosporin intermediate 7α-methoxy cephalothin and method for preparing same

Polymorphs

Polymorphs

Crystalline forms of MNK inhibitors

Dimethylaminoethanol salt of a GLP-1 receptor modulator

Process for preparation of empagliflozin or its co-crystals, solvates and their polymorphs thereof

Solid forms of 4-(2-fluoro-4-(1-methyl-1H-benzo[d]imidazol-5-yl)benzoyl)piperazin-1-yl)(1-hydroxycyclopropyl)methanone

Pharmaceutical formulations of N-(2-(2-(dimethylamino) ethoxy)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylamide and salts thereof

Crystalline 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione dihydrate, compositions and methods of use thereof

Crystal forms of amino lipids

Process to prepare a solid composition of an amino acid diacetic acid

Polymorphic compounds and uses thereof

Morphic forms of G1T38 and methods of manufacture thereof

Salt of cetagliptin, preparation method thereof, pharmaceutical composition, and use thereof

Manufacturing process and intermediates for a pyrrolo[2,3-d]pyrimidine compound and use thereof

Solid form of (S)-[2-chloro-4-fluoro-5-(7-morpholin-4-yl-quinazolin-4-yl)phenyl]-(6-methoxy-pyridazin-3-yl)-methanol

Purification of cannabinoids from crude cannabis oil

LOW HYGROSCOPIC ARIPIPRAZOLE DRUG SUBSTANCE AND PROCESSES FOR THE PREPARATION THEREOF

Crystalline form of 1-(5-(2,4-difluorophenyl)-1-((3-fluorophenyl)sulfonyl)-4-methoxy-1H-pyrrol-3-yl)-N-methylmethanamine salt

Acetylsalicylic acid derivative crystal, its preparation method and use

KRas G12C inhibitors

CRYSTALLINE FORMS OF A PROLYL HYDROXYLASE INHIBITOR

Amorphous and crystalline forms of IDO inhibitors

Crystal form of dezocine and preparation method therefor

Process for the preparation of 1,5-benzothiazepine compounds

Process for the preparation of 6-(cyclopropaneamido)-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)amino)-N-(methyl-d3)pyridazine-3-carboxamide

Methods for preparing levorphanol and related compounds, and compositions thereof

Method for preparing chromium(III) pyridine-2-carboxylate using 2-OP rectification residues

Solid state forms of N-[2-[(I S)-1-(3-ethoxy-4-methoxyphenyl)-2-(methyl sulfonyl)ethyl]-2,3-dihydro-1,3-dioxo-L H-isoindol-4-yl]acetamide and process for preparation thereof

STAT3 inhibitor formulation

PDE4 inhibitor (R)-4-(5-(4-methoxy-3-propoxyphenyl)pyridin-3-yl)-1,2-oxaborolan-2-ol

Imidazo[2,1-f][1,2,4]triazine compounds as pi3k-y inhibitors

Crystals of azabicyclic compound

Crystalline form of masitinib

Methods for preparing substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine

CRYSTALLINE FORMS OF (-)-(1R,2R)-3-(3-DIMETHYLAMINO-1-ETHYL-2-METHYLPROPYL)-PHENOL HYDROCHLORIDE

Piezoelectric device comprising an amino acid crystal

Crystal of oxidized glutathione dication salt and production method therefor

Crystalline forms of Ponatinib hydrochloride

Crystalline forms of seletalisib

Process for the preparation of substituted oxiranes and triazoles

Crystalline forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl] amino} acetic acid and processes for preparation thereof

Crystalline (R)-5-carbamoylpyridin-3-yl-2-methyl-4-(3-(trifluoromethoxy)benzyl)piperazine-1-carboxylate, compositions and methods of use thereof

Polymorphic compounds and uses thereof

Zinc oxide complexes

Process for the preparation of allopregnanolone

Nucleotide hemi-sulfate salt for the treatment of hepatitis C virus

Process for the preparation of tavaborole, its novel polymorphic forms and the polymorphs thereof

Compositions and methods related to pyridinoylpiperidine 5-HTagonists

Nicotine salts, co-crystals, and salt co-crystal complexes

PROCESS FOR THE PRODUCTION OF OZANIMOD

Method of preparing (3R,4S)-3-acetamido-4-allyl-n-(tert-butyl)pyrrolidine-3-carboxamide

Method for treating a suspension of solid particles in water using a (co)polymer of a hydrated crystalline form of 2-acrylamido-2-methylpropanesulfonic acid

Enhanced oil recovery method using a (co)polymer of a hydrated crystalline form of 2-acrylamido-2-methylpropane sulfonic acid

Nucleating agents, methods for their production, and associated polymer compositions

Process to convert technical ascomycin into purified pimecrolimus

Crystalline form of Eluxadoline

Menaquinol compositions and methods of treatment

Salts and crystal forms of GABApositive allosteric modulator

Compound of EOC315 Mod.I crystal form and preparation method thereof

Crystalline forms of a phosphoinositide 3-kinase (PI3K) inhibitor

Combinations for treatment of NASH/NAFLD and related diseases

Crystalline form of aripiprazole

Salts of an LSD1 inhibitor and processes for preparing the same

Crystalline form of dextral oxiracetam, preparation method therefor and use thereof

Leonurine crystal and use thereof in preparation of insulin sensitizer, hypoglycemic drug and lipid-lowering drug

2,2-difluoropropionamide derivatives of bardoxolone methyl, polymorphic forms and methods of use thereof

High-purity D-psicose preparation method

Crystalline forms of valbenazine salts

Process for the manufacture of R-6-hydroxy-8-[1-hydroxy-2-[2-(4-methoxyphenyl)-1,1-dimethylethylaminoethyl]-2H-1,4-benzoxazin-3(4H)-one hydrochloride

NOVEL CRYSTALLINE FORMS

Polymorphic forms of RAD1901-2HCl

Combinations of a 4-pyrimidinesulfamide derivative with active ingredients for the treatment of endothelin related diseases

Octamolybdate compounds exhibiting bright emission

Solid forms of substituted benzoxaborole and compositions thereof

[1,2,4]triazolo[4,3-B]pyridazines for use in the treatment of proliferative diseases

Tebipenem pivoxil crystalline forms, compositions including the same, methods of manufacture, and methods of use

Polymorphs

Method for manufacturing diastereomer of citric acid derivative

Fracturing fluid comprising a (co)polymer of a hydrated crystalline form of 2-acrylamido-2-methylpropane sulphonic acid and hydraulic fracturing method

Method for isolation and purification of naltrexone

Cocrystal

Solid state forms of valbenazine

Opioid receptor (MOR) agonist salt, fumarate salt crystal form I thereof and preparation method thereof

Polymorph of pazopanib hydrochloride and preparation process thereof

Pharmaceutical formulations of tropomyosin related kinase (TRK) inhibitors

Process of making somatostatin modulators

Sodium ion channel inhibitors and pharmaceutically acceptable salts and polymorphs thereof and uses thereof

Method for separating and purifying 2-chloro-3-trifluoromethylpyridine

Crystalline form of (R)-4-hydroxy-2-oxo-1-pyrrolidineacetamide, preparation method therefor and use thereof

CRYSTALLINE DIACYLHYDRAZINE AND THE USE THEREOF

METHOD FOR PRODUCING ALLULOSE CRYSTALS

Methods for treating ulcerative colitis using 3-((1R,3s,5S)-3-((7-((5-methyl-1H-pyrazol-3-yl)amino)-1,6-naphthyridin-5-yl)amino)-8-azabicyclo[3.2.1]octan-8-yl)propanenitrile

Crystalline polymorphs of a muscarinic acetylcholine receptor agonist

Polymorphic form of compound, preparation method and use thereof

Short-acting benzodiazepine salts and their polymorphic forms

Crystal form A of 2-butoxy-7-(4-(pyrrolidin-1-ylmethyl)benzyl)-5H-pyrrolo[3,2-d]pyrimidin-4-amine for inhibiting toll-like receptor activity

Crystalline binary sodium salts of 5-methyl-(6S)-tetrahydrofolic acid with organic bases

Solid form of azetidine derivative and preparation method therefor and use thereof

Forms of afatinib dimaleate

Benzimidazole derivatives as bromodomain inhibitors

Process for preparing fluorescein quinoid form

Organic crystalline salt of haloacetic acid

Method for preparing single crystal of anhydrous halogenated choline or derivative thereof

Process for making beta 3 agonists and intermediates

Process for synthesis of eliglustat and intermediate compounds thereof

Solid forms of cerdulatinib

OZANIMOD ADDITION SALT CRYSTAL, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION, AND USES

Non-solvated crystal, preparation method and application thereof

Process for preparation of boscalid anhydrate form I and boscalid anhydrate form II

NOVEL POLYMORPHS OF (5-[3-(3-HYDROXYPHENOXY)AZETIDIN-1-YL]-5-METHYL-2,2-DIPHENYLHEXANAMIDE HYDROCHLORIDE

Hydrated crystalline form of 2-acrylamido-2-methylpropane sulfonic acid

Crystalline epinephrine malonate salt

Crystalline monosodium salt of 5-methyl-(6S)-tetrahydrofolic acid

CRYSTALLINE FORMS OF A BILE ACID DERIVATIVE

Solid forms of [(1 S)-1 -[(2S,4R,5R)-5-(5-amino-2-oxo-thiazolo[4,5-D]pyrimidin-3-yl)-4-hydroxy-tetrahydrofuran-2-Yl]proptl] acetate

ENANTIOMERICALLY PURIFIED GPER ANGONIST FOR USE IN TREATING DISEASE STATES AND CONDITIONS

Triazinium cation forms and methods of making thereof

Antifungal compound process

Process for preparation of apalutamide

Elagolix sodium compositions and processes

Crystal form and salt form of and preparation method for tyrosine kinase inhibitor

(+)-3-(2,3-difluorophenyl)-3-methoxypyrrolidine or pharmaceutically acceptable salts thereof, a process for preparation thereof and uses thereof

CRYSTALLINE SALTS OF (4S,4AS,5AR,12AS)-4-DIMETHYLAMINO-3,10,12,12A-TETRAHYDROXY-7-[(METHOXY(METHYL)AMINO)-METHYL]-1,11-DIOXO-1,4,4A,5,5A,6,11,12A-OCTAHYDRO-NAPHTHACENE-2-CARBOXYLIC ACID AMIDE AND METHODS OF USING THE SAME

Crystalline forms

Crystalline forms of a Janus kinase inhibitor

(E)-1-(4-(dimethylamino)but-2-enoyl)pyrrolidin-3-yl 4-((3-isopropyl-5-methylpyrazolo[1,5-a]pyrimidin-7-yl)amino)piperidine-1-carboxylate for inhibiting CDK7

Polymorphic forms of Cyclo (-His-Pro)

NOVEL CO-CRYSTALS

Small Molecule Inhibitors of the JAK Family of Kinases

Process for the preparation of rivaroxaban involving novel intermediate

SURFACTANT SYSTEMS FOR CRYSTALLIZATION OF ORGANIC COMPOUNDS

Crystal of N-substituted sulfonamide compound

Cocrystal of 2-(6-methyl-pyridine-2-yl)-3-yl-[6-amide-quinoline-4-yl]-5,6-dihydro-4H-pyrrole[1,2-b]pyrazole, preparation method therefor, and pharmaceutical composition

Crystalline forms of 1-(4-{[6-amino-5-(4-phenoxy-phenyl)-pyrimidin-4-ylamino]-methyl}-piperidin-1-yl)-propenone

Niraparib compositions

Quinoline derivative in crystal form

Urea derivative

Stevioside M crystal form, preparation method therefor and use thereof

Crystalline forms of 5-chloro-N4-[-2-(dimethylphosphoryl) phenyl]-N2-{2-methoxy-4-[4-(4-methylpiperazin-1-yl) piperidin-1-yl] phenyl} pyrimidine-2,4-diamine

SOLID STATE FORMS OF MIDOSTAURIN

Polymorphic form of sepiapterin

Formulations of a compound modulating kinases

Pyridone derivatives having tetrahydropyranylmethyl groups

Precipitation method and synthesis method of 2,6-diamino-3,5-dinitropyrazine-1-oxide

Process for preparation and purification of vortioxetine hydrobromide

Forms of apremilast

Crystalline form of tefluthrin, process for its preparation and use thereof

Formulations of pimavanserin

Process for preparation of regadenoson and polymorphs thereof

Polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparations

Crystalline form of Ribociclib succinate

Salts of an FGFR inhibitor

Solid forms of 3-((1R,3R)-1-(2,6-difluoro-4-((1-(3- fluoropropyl)azetidin-3-yl)amino)phenyl)-3-methyl-1,3,4,9-tetrahydro-2H-pyrido[3,4-b]indol-2-yl)-2,2-difluoropropan-1-ol and processes for preparing fused tricyclic compounds comprising a substituted phenyl or pyridinyl moiety, including methods of their use

Crystalline forms of a 4-pyrimidinesulfamide derivative aprocitentan

Solid forms comprising (1E, 4E)-2-amino-N,N-dipropyl-8-(4-(pyrrolidine-1-carbonyl)phenyl)-3H-benzo[B]azepine-4-carboxami compositions thereof, and uses thereof

Method for purifying crystals using solvent vapors

Crystal modifications of odevixibat

Crystalline forms of 3-Z-[1-(4-(N-((4-methyl-piperazin-1-yl)-methylcarbonyl)-N-methyl-amino)-phenylamino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone

Solid forms of substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine compounds

Forms of (R)-N-(4-chlorophenyl)-2-(cis-4-(6-fluoroquinolin-4- yl)cyclohexyl)propanamide

Formulations of an AXL/MER inhibitor

Solid state forms of rucaparib and of rucaparib salts

COMPOUND

Crystalline brexpiprazole

Ethane-sulfonate salt of quinoline derivative

Crystal form and salt of 3-(3,5-dichloro-4-hydroxybenzoyl)-1,1-dioxo-2,3-dihydro-1,3-benzothiazole

Crystal forms of the monosodium salt of foramsulfuron

Solid state forms of netarsudil mesylate

Method for the purification of natural vanillin

Crystalline salt forms

Prodrug of an HCV NS5B polymerase inhibitor and method of production and application thereof

CRYSTAL FORM COMPRISING LITHIUM IONS, PHARMACEUTICAL COMPOSITIONS THEREOF, METHODS FOR PREPARATION AND THEIR USES FOR THE TREATMENT OF DEPRESSIVE DISEASE

Forms of a PI3K delta selective inhibitor for use in pharmaceutical formulations

Crystal form of ACP-196, preparation method therefor and pharmaceutical composition thereof

Method for producing diphenylmethane derivative

LFA-1 inhibitor and methods of preparation and polymorph thereof

GLP-1 receptor agonists and uses thereof

GLP-1 receptor agonists and uses thereof

GLP-1 receptor agonists and uses thereof

Crystalline forms of 1-((2R,4R)-2-(1H-benzo[d]imidazol-2-yl)-1-methylpiperidin-4-yl)-3-(4-cyanophenyl)urea maleate

Methods of synthesizing thyroid hormone analogs and polymorphs thereof

IDIOPATHIC PULMONARY FIBROSIS-DETECTION, MONITORING, PREDICTION METHODS

Carbidopa prodrug

SALTS OF A HETEROCYCLIC COMPOUND AND CRYSTALLINE FORMS, PROCESSES FOR PREPARING, THERAPEUTIC USES, AND PHARMACEUTICAL COMPOSITIONS THEREOF

Salt type and crystal type of 4h-pyrazolo [1, 5-alpha] benzimidazole compound and preparation method and intermediate thereof

Crystal form of ACP-196 salt and preparation method, pharmaceutical composition, and use thereof

HYDROCHLORIDE SALTS OF 8-[{1-(3,5-BIS-(TRIFLUOROMETHYL)PHENYL)-ETHOXY}-METHYL]-8-PHENYL-1,7-DIAZA-SPIRO[4.5]DECAN-2-ONE AND PREPARATION PROCESS THEREFOR

Process and crystalline forms of lumacaftor

Molecular host frameworks and methods of making and using same

PHARMACEUTICAL CO-CRYSTAL COMPOSITION AND USE THEREOF

Scalable polypropionate lactone stereotetrads

Antifungal compounds and processes for making

CRYSTAL FORM OF QUINOLINE COMPOUND AND PROCESS FOR ITS PRODUCTION

(R)-4-hydroxy-2-oxo-1-pyrrolidineacetamide crystal form, preparation method therefor, and application thereof

COMBINATION THERAPY OF BACE-1 INHIBITOR AND ANTI-N3PGLU ABETA ANTIBODY

Crystalline form of lorlatinib free base

Process for the preparation of Remimazolam and solid state forms of Remimazolam salts

Process for the preparation of crystalline form C of avibactam sodium

Crystal forms of glutaminase inhibitors

Processes for the preparation of 7-{4-[4-(1-benzothiophen-4-yl) piperazin-1-yl]butoxy}quinolin-2(1H)-one

Methods and compositions for gamma-glutamyl cycle modulation

Aqueous leaching method to produce microcrystalline powder

Crystalline phases of 5,6-dichloro-2-(isopropylamino)-(1-beta-L-ribofuranosyl)-1H-benzimidazole

Crystalline forms of viral-protein inhibitor drug VX-787, processes for preparation thereof and use thereof

EBNA1 inhibitor crystalline forms, and methods of preparing and using same

Crystalline forms of 4-(tert-butoxyamino)-6-(6-(trifluoromethyl)pyridin-2-yl)-N-(2-(trifluoromethyl)pyridin-4-yl)-1,3,5-triazin-2-amine methanesulfonic acid salt

Method for producing a polymorphic form of 3-[5-amino-4-(3- cyanobenzoyl)-pyrazol-1-yl]-N-cyclopropyl-4-methylbenzamide

Injectable suspension comprising 3-beta-hydroxy-5-alpha-pregnan-20-one, and a method for the manufacturing thereof

Crystalline platinum-based compounds

Crystalline forms of 4-(5-(4,7-dimethylbenzofuran-2-yl)-l,2,4-oxadiazol-3-yl)benzoic acid and processes for their preparation

Crystal form of tipifarnib and preparation method and pharmaceutical composition thereof

Crystalline forms of selective S1P1 receptor modulator and preparation method thereof

Eluxadoline crystalline forms and processes for their preparation

Solid state forms of Lenvatinib Mesylate

Process for the preparation of a PDE4 inhibitor

Crystalline modifications of N-(4,5-bismethanesulfonyl-2-methylbenzoyl)guanidine hydrochloride and N-(4,5-bismethanesulfonyl-2-methylbenzoyl)guanidine salts

Crystalline Maltitol Powder Less Prone to Consolidation and Method for Production Thereof

Crystalline forms of benzoquinoline inhibitors of vesicular monoamine transporter 2